Radiopharma on a gradual recovery path Import alert slows growth prospects in the Generic segm...
Import alert on Roorkee facility Jubilant Pharmova (Jubilant) announced that it has received i...
Big miss; recovery delayed Jubilant Pharmova’s (Jubilant) Q4FY21 performance was below o...
Demand prospects favorable; execution remains the key * Jubilant Pharmova (JP) hosted an inve...
Radiopharma business recovery – key for better outlook CDMO prospects remain promising ...
CMO outlook bright; Radiopharma in gradual recovery mode All segments showing strong growth *...
Buy Jubilant Life Sciences Ltd For Target Rs. 1,120 CMO outlook bright; Radiopharma in gradual...
Demerger may complete in FY21 Jubilant Life Sciences (JLS) has recently received the NCLT app...